Ah, yes, saving the little children! Protecting the elderly! Your child with autism stands in the way of commerce, friends. Read more about this $300 teleconference HERE.
The vaccine industry has flourished during the Bush Administrations: Government support has flowed to the industry for new facilities, new technologies and new markets. Important new vaccines have been approved for pediatric, adolescent, and adult diseases.
Biodefense initiatives and proactive programs on natural disease disasters (like pandemic influenza) dominated the Bush Administration's vaccine agenda. The stimulus to research and commercial capacity was immense: a dramatic change for a previously overlooked sector of the biopharma field.
Will the government remain an active, supportive partner for vaccines in the new administration, or will the renaissance wane? New forms of government support are possible from the Obama Administration:
Incentives for first-dollar coverage for vaccines
Incentives to providers for increased vaccination rates
New programs for vaccines for the adult and young adult populations
Increased support for international efforts to increase uptake and administration of vaccines for diseases in the developing world
Our webinar team of experienced Washington policy experts will provide a look ahead to the next four years for this important part of the biopharmaceutical industry and the public health protection. There are clear opportunities and challenges for the vaccine industry in the next four years.
The emerging Obama health team has experience in the field; they bring preconceived approaches and tendencies to the field. Many trained in public health roles during the initiation of the Vaccines for Children Program. Now is the time to understand the background and to analyze how they will approach the changes that have occurred in the vaccine industry in the past eight years.
Take away key perspectives and guidance in the following areas:
How do vaccines fit into the developing overall health care reform effort that promises to be a key part of the Obama economic revitalization?
What is the future for “push” incentives for vaccines: funding for research; funding for new production capacity; support for regulatory approvals?
Is the government ready to continue and support “pull” programs: efforts to expand vaccination populations for flu vaccines, for vaccines for adolescents, for vaccines for the elderly?
How far will the government go to assure the public that safety fears are unfounded?
Who will be the key voices for vaccines in the new administration?
...and much more!
Join us for Vaccines: Is the Boom Sustainable during the Obama Era? on Thursday, Jan. 29, 2009 at 12 p.m. EST (9 a.m. Pacific). Listen as our experts help you understand the future before it's begun. Grab your team, a phone and a computer with Web access (that last one's optional). No travel required!